Early acetabular fracture repair through an anterior approach is associated with increased blood loss

Author:

Ambrose Michael1,Schulman Jeff E.1,Kuenze Christopher2,Hymes Robert A.1,Holzman Michael1,Malekzadeh A. Stephen1,Ray-Zack Mohamed1,Gaski Greg E.1ORCID

Affiliation:

1. Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church, Virginia, USA

2. Department of Kinesiology, University of Virginia, Charlottesville, VA, USA

Abstract

OBJECTIVES: To determine whether the timing of acetabular fracture fixation through an anterior approach influences estimated and calculated perioperative blood loss. METHODS: Design: Retrospective cohort study. Setting: Level 1 trauma center from 2013 to 2021. Patient Selection Criteria: Patients age >18 treated with acetabular fracture fixation through an anterior-based approach. Outcome Measures and Comparisons: The primary outcome was calculated blood loss (CBL). Secondary outcomes were estimated blood loss (EBL) reported by surgeon and anesthesia, and blood transfusion requirements. Comparisons of blood loss were made at discrete post-injury time thresholds (24, 36, and 48 hours) and on a continuous basis. RESULTS: 108 patients were studied. The mean age was 65 and 73% of patients were male. Earlier fixation of acetabular fractures resulted in greater CBL and EBL (surgeon and anesthesia) compared to later fixation when analyzed on a continuum and at specific time points (24, 36, and 48 hours). Mean CBL in patients treated earlier (< 48hrs, 2539 ml +/-1194) was significantly greater than those treated later (>48 hrs, 1625 ml +/-909; p<0.001). Fracture repair before 48 hours post-injury was associated with a 3 times greater risk of >2000 ml of CBL (p=0.006). This did not result in differences in transfusion rates between groups at 24 hours (p=0.518), 36 hours (p=1.000) or 48 hours (p=0.779). CONCLUSIONS: Delaying fixation of acetabular fractures treated through an anterior approach for 48 hours post-injury may significantly reduce perioperative blood loss. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference20 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3